title: Rapid improvement of hypoxemia by the use of rituximab in patients with pulmonary intravascular lymphoma.
authors.forename: Kosei
authors.initials: K
authors.lastname: Matsue
authors.forename: Masami
authors.initials: M
authors.lastname: Takeuchi
authors.forename: Hidetaka
authors.initials: H
authors.lastname: Uryu
authors.forename: Mihoko
authors.initials: M
authors.lastname: Koseki
authors.forename: Noboru
authors.initials: N
authors.lastname: Asada
authors.forename: Yosinori
authors.initials: Y
authors.lastname: Kaneko
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008875:Middle Aged; D011651:Pulmonary Artery / Q000473:pathology; D000069283:Rituximab; D019043:Vascular Neoplasms / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab